RACHEL DELFINO BRILES: Open Payments
NPI 1063988178 · KINGMAN, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 14 payments from 9 companies in 2025. Trend: 2023 $573 · 2024 $215 · 2025 $298
Food & beverage: $228Education: $70
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 3 | $75 |
| SANOFI-AVENTIS U.S. LLC | 1 | $70 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Grifols USA, LLC | 1 | $28 |
| UCB, Inc. | 1 | $23 |
| Electromed, Inc. | 3 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $15 |
| United Therapeutics Corporation | 1 | $14 |
Products named: DUPIXENT, UPTRAVI, Prolastin-C Liquid, Bimzelx, SMARTVEST, BREZTRI, JASCAYD, inCourage Airway Clearance Therapy.
Industry payments across AZ — which companies pay providers there.
